Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$5,773,628
+$1,859,243 QoQ
Shares Held
22,944
+27.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.93%
of 13F equity value
Holder Rank
#1,226
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 5%
Shared 0%
None 95%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MONECO ADVISORS, LLC holds $43,364,399 across 12 Drug Manufacturers - General names. ABBV ranks #3 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
64,501 | $16,381,318 | |
| 2 | LLY |
ELI LILLY & Co
|
6,143 | $7,368,099 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
22,944 | $5,773,628 | |
| 4 | PFE |
Pfizer Inc
|
170,546 | $4,106,747 | |
| 5 | GSK |
GSK plc
|
60,767 | $3,185,406 | |
| 6 | MRK |
Merck & Co., Inc.
|
18,894 | $2,427,879 | |
| 7 | AMGN |
Amgen Inc
|
4,401 | $1,593,690 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
11,852 | $682,912 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,773,628 | 22,944 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $3,914,385 | 17,998 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $4,150,292 | 18,164 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $3,999,158 | 17,272 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $3,171,503 | 17,086 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,522,869 | 16,814 | Shares | Sole | 2025-08-15 | |
| 2024-12-31 | $3,035,116 | 17,080 | Shares | Sole | 2025-08-15 | |
| 2024-09-30 | $2,862,275 | 14,494 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $2,342,620 | 13,658 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $2,256,765 | 12,393 | Shares | Sole | 2024-07-19 | |
| 2023-12-31 | $1,388,376 | 8,959 | Shares | Sole | 2024-03-13 | |
| 2023-09-30 | $1,483,743 | 9,954 | Shares | Sole | 2024-03-13 | |
| 2023-06-30 | $1,190,878 | 8,839 | Shares | Sole | 2024-03-13 | |
| 2023-03-31 | $1,455,685 | 9,134 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,129,169 | 6,987 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $934,504 | 6,963 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $1,059,714 | 6,919 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,077,220 | 6,645 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $903,118 | 6,670 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $742,037 | 6,879 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $704,901 | 6,258 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $668,799 | 6,180 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $585,896 | 5,468 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $427,877 | 4,885 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $440,140 | 4,483 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $319,921 | 4,199 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||